HEALTHSTORY 524· AUGUST 2, 2026

Trump administration shifts 340B drug program from upfront discounts to rebates, drawing hospital backlash

A federal law requires pharmaceutical manufacturers to sell discounted medicines to specific hospitals and clinics. That discount mechanism, the foundation of the 340B Drug Pricing Program, is now being reshaped. The Trump administration…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 523Amazon to return $600 million in tariff refunds to some customers after Supreme Court ruling NEXT STORY 525 →Iran warns of retaliation if the United States follows through on attack threats

Keep reading

More from the desk.

07HEALTH

Childhood cancer drugs cause liver-aging mutations, Science study finds

A group of drugs that transformed survival rates for children with liver cancer have been found to cause genetic mutations in healthy liver tissue that speed up how fast the organ ages. The drugs are platinum-based chemotherapy agents, a…

health1 MIN

15HEALTH

Vaccine mandates on the ballot: five midterm races where school shot requirements are the fight

Vaccine mandates, the laws specifying which inoculations children must receive before they can enroll in public school, have become a prominent issue in at least five midterm races ahead of November's elections. Republican candidates in…

health2 MIN

19HEALTH

U.S. agency commits $62.7 million to build FDA-authorized AI for heart failure care

A federal health research agency is committing $62.7 million to develop artificial intelligence systems designed to help manage heart failure, where heart failure means the heart muscle can no longer pump enough blood to meet the body's…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk